Untreated Treated pEC 50 a E max b pK a c log d n pEC 50 a E max b pK a c log d n RAMP1 CGRP 9.66 Ϯ 0.2 47.07 Ϯ 2.2 9.43 Ϯ 0.2 Ϫ0.11 Ϯ 0.04 9 9.65 Ϯ 0.2 44.95 Ϯ 2.2 9.33 Ϯ 0.3 Ϫ0.11 Ϯ 0.07 6 AM 7.93 Ϯ 0.2 48.06 Ϯ 2.5 7.67 Ϯ 0.2 Ϫ0.09 Ϯ 0.05 9 8.14 Ϯ 0.07 72.17 Ϯ 1.7*** 7.66 Ϯ 0.2 0.36 Ϯ 0.
The negative logarithm of the agonist concentration required to produce a half-maximal response.
b The maximal response to the ligand expressed as a percentage of the maximal cAMP production as determined using 100 M forskolin stimulation in the presence of pertussis toxin treatment. c The negative logarithm of the equilibrium disassociation constant for each ligand generated through use of the operational model of agonism (34). d Log is the coupling efficiency parameter of each ligand.
TABLE 4
Potency (pEC 50 ) and maximal response (E max ), for cAMP production at the CLR co-expressed with each RAMP, stimulated with various agonists measured in HEK-293S cells in the presence or absence of pertussis toxin Data are the mean Ϯ S.E. of n individual data sets. No statistical difference was found between untreated and PTX-treated HEK-293S cells using Student's t test. The negative logarithm of the agonist concentration required to produce a half-maximal response.
b The maximal response to the ligand expressed as a percentage of the maximal cAMP production as determined using 100 M forskolin stimulation in the presence of PTX treatment. 
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